Brain Cancer Canada (BCC) is launching a nationwide campaign for Brain Cancer Awareness Month this May, focusing on increasing visibility and funding for brain cancer research. The initiative includes illuminating iconic landmarks across Canada, highlighting the urgency of addressing a disease that remains significantly underfunded. Angela Scalisi, Chair of BCC, emphasizes that the campaign aims not only to raise awareness but also to catalyze action and investment in research that can transform outcomes for patients and families affected by brain cancer.

Since its inception in 2015, BCC has funded 31 research projects across various institutions, directing nearly $3 million toward innovative therapies and scientific advancements. The organization is particularly committed to supporting research on aggressive brain cancers like glioblastoma, which has a dismal prognosis and limited survival rate improvements over the past decades. By fostering collaboration among leading researchers, BCC aims to enhance understanding, diagnosis, and treatment of brain tumors, thereby addressing one of the most pressing challenges in oncology today.

The upcoming Gala for Brain Cancer Research on May 22 will serve as a pivotal fundraising event, uniting advocates, supporters, and those affected by brain cancer to generate essential funds for research. With keynote insights from Dr. Cynthia Hawkins, a leading pathologist in pediatric brain tumors, this event underscores the critical need for early-stage research funding that can lead to transformative treatment options. BCC’s volunteer-driven model ensures that contributions directly impact research efforts, reinforcing the importance of community engagement in advancing brain cancer science and improving patient outcomes.

Source: globenewswire.com